# C4 Therapeutics, Inc.: Form 8-K, filed Jun 24, 2022

- Company: [C4 Therapeutics, Inc.](/companies/cccc.md) (CIK 1662579)
- Form: 8-K
- Filed: 2022-06-24
- Accepted by EDGAR: Jun 24, 2022, 16:00 ET
- Period: 2022-06-22
- Accession: 0001564590-22-024179
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662579/000156459022024179/cccc-8k_20220622.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662579/000156459022024179/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662579/000156459022024179/cccc-8k_20220622.htm

Filed Jun 24, 2022.
Source: SEC EDGAR, the filing index for accession 0001564590-22-024179. Last ingested by Listed: Nov 5, 2026, 12:02 ET. No prices; not investment advice.